ABSTRACT
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease affecting upper and lower motor neurons (MNs). Neuregulin-1 (NRG1) is a pleiotropic growth factor that has been shown to be potentially valuable for ALS when supplemented by means of viral-mediated gene therapy. However, these results are inconsistent with other reports. An alternative approach for investigating the therapeutic impact of NRG1 on ALS is the use of transgenic mouse lines with genetically defined NRG1 overexpression. Here, we took advantage of a mouse line with NRG1 type III overexpression in spinal cord α motor neurons (MN) to determine the impact of steadily enhanced NRG1 signalling on mutant superoxide dismutase 1 (SOD1)-induced disease. The phenotype of SOD1G93A-NRG1 double transgenic mice was analysed in detail, including neuropathology and extensive behavioural testing. At least 3 animals per condition and sex were histopathologically assessed, and a minimum of 10 mice per condition and sex were clinically evaluated. The accumulation of misfolded SOD1 (mfSOD1), MN degeneration, and a glia-mediated neuroinflammatory response are pathological hallmarks of ALS progression in SOD1G93A mice. None of these aspects was significantly improved when examined in double transgenic NRG1-SOD1G93A mice. In addition, behavioural testing revealed that NRG1 type III overexpression did not affect the survival of SOD1G93A mice but accelerated disease onset and worsened the motor phenotype.
Subject(s)
Amyotrophic Lateral Sclerosis , Neurodegenerative Diseases , Mice , Animals , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/therapy , Amyotrophic Lateral Sclerosis/metabolism , Superoxide Dismutase-1/genetics , Neuregulin-1/genetics , Neurodegenerative Diseases/metabolism , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Motor Neurons/pathology , Mice, TransgenicABSTRACT
Resistance to cancer therapy is a challenge because of innate tumor heterogeneity and constant tumor evolution. Since the pathway of resistance cannot be predicted, combination therapies may address this progression. We discovered that in addition to IGF1 and IGF2, IGFBP-3 binds bFGF, HGF, neuregulin, and PDGF AB with nanomolar affinity. Because growth factors drive resistance, simultaneous inhibition of multiple growth factor pathways may improve the efficacy of precision therapy. Growth factor sequestration by IGFBP-3-Fc enhances the activity of EGFR inhibitors by decreasing cell survival and inhibiting bFGF, HGF, and IGF1 growth factor rescue and also potentiates the activity of other cancer drugs. Inhibition of tumor growth in vivo with adjuvant IGFBP-3-Fc with erlotinib versus erlotinib after treatment cessation supports that the combination reduces cell survival. Inhibition of multiple growth factor pathways may postpone resistance and extend progression-free survival in many cancer indications.
Subject(s)
ErbB Receptors/genetics , Erlotinib Hydrochloride/pharmacology , Gene Expression Regulation, Neoplastic , Insulin-Like Growth Factor Binding Protein 3/genetics , Lung Neoplasms/drug therapy , Protein Kinase Inhibitors/pharmacology , Tumor Burden/drug effects , Animals , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Drug Resistance, Neoplasm/drug effects , Drug Resistance, Neoplasm/genetics , ErbB Receptors/antagonists & inhibitors , ErbB Receptors/metabolism , Fibroblast Growth Factors/genetics , Fibroblast Growth Factors/metabolism , HEK293 Cells , HT29 Cells , Hepatocyte Growth Factor/genetics , Hepatocyte Growth Factor/metabolism , Humans , Immunoglobulin Fc Fragments/pharmacology , Insulin-Like Growth Factor Binding Protein 3/antagonists & inhibitors , Insulin-Like Growth Factor Binding Protein 3/metabolism , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/metabolism , Insulin-Like Growth Factor II/genetics , Insulin-Like Growth Factor II/metabolism , Lung Neoplasms/genetics , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , MCF-7 Cells , Male , Mice , Mice, Inbred NOD , Neuregulin-1/genetics , Neuregulin-1/metabolism , Platelet-Derived Growth Factor/genetics , Platelet-Derived Growth Factor/metabolism , Signal Transduction , Xenograft Model Antitumor AssaysABSTRACT
Deficits in neuronal migration during development in the central nervous system may contribute to psychiatric diseases. The ligand neuregulin1 (NRG1) and its receptor ErbB4 are genes conferring susceptibility to schizophrenia, playing a key role in the control of neuronal migration both during development and adulthood. Several NRG1 and ErbB4 isoforms were identified, which deeply differ in their characteristics. Here we focused on the four ErbB4 isoforms and the two NRG1 isoforms differing in their EGF-like domain, namely α and ß. We hypothesized that these isoforms, which are differently regulated in schizophrenic patients, could play different roles in neuronal migration. Our hypothesis was strengthened by the observation that both NRG1α and NRG1ß and the four ErbB4 isoforms are expressed in the medial and lateral ganglionic eminences and in the cortex during development in rat. We analysed in vitro the signal transduction pathways activated by the different ErbB4 isoforms following the treatment with soluble recombinant NRG1α or NRG1ß and the ability to stimulate migration. Our data show that two ErbB4 isoforms, namely JMa-cyt2 and JMb-cyt1, following NRG1α and NRG1ß treatment, strongly activate AKT phosphorylation, conferring high migratory activity to neuronal progenitors, thus demonstrating that both NRG1α and NRG1ß can play a role in neuronal migration.
Subject(s)
Cell Movement , Neural Stem Cells/metabolism , Neuregulin-1/metabolism , Receptor, ErbB-4/metabolism , Animals , Cell Line , Cerebral Cortex/cytology , Cerebral Cortex/embryology , Cerebral Cortex/metabolism , Hypothalamus/cytology , Hypothalamus/embryology , Hypothalamus/metabolism , Neural Stem Cells/physiology , Neuregulin-1/genetics , Neurogenesis , Phosphorylation , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Processing, Post-Translational , Proto-Oncogene Proteins c-akt/metabolism , Rats , Rats, Wistar , Receptor, ErbB-4/geneticsABSTRACT
Obesity reduces breastfeeding success and lactation performance in women. However, the mechanisms involved are not entirely understood. In the present study, female C57BL/6 mice were chronically exposed to a high-fat diet to induce obesity and subsequently exhibited impaired offspring viability (only 15% survival rate), milk production (33% reduction), mammopoiesis (one-third of the glandular area compared to control animals) and postpartum maternal behaviors (higher latency to retrieving and grouping the pups). Reproductive experience attenuated these defects. Diet-induced obese mice exhibited high basal pSTAT5 levels in the mammary tissue and hypothalamus, and an acute prolactin stimulus was unable to further increase pSTAT5 levels above basal levels. In contrast, genetically obese leptin-deficient females showed normal prolactin responsiveness. Additionally, we identified the expression of leptin receptors specifically in basal/myoepithelial cells of the mouse mammary gland. Finally, high-fat diet females exhibited altered mRNA levels of ERBB4 and NRG1, suggesting that obesity may involve disturbances to mammary gland paracrine circuits that are critical in the control of luminal progenitor function and lactation. In summary, our findings indicate that high leptin levels are a possible cause of the peripheral and central prolactin resistance observed in obese mice which leads to impaired lactation performance.
Subject(s)
Lactation/physiology , Leptin/metabolism , Mammary Glands, Animal/metabolism , Obesity/metabolism , Prolactin/metabolism , Animals , Diet, High-Fat , Female , Hypothalamus/metabolism , Mice , Mice, Inbred C57BL , Mice, Obese , Neuregulin-1/genetics , RNA, Messenger/biosynthesis , Receptor, ErbB-4/genetics , STAT5 Transcription Factor/metabolismABSTRACT
Neuregulin 1 (Nrg1) is one of the most active members of the epidermal growth factor (EGF)-like family, which bind to the ErbB tyrosine kinase receptor and play many roles in modulation of synaptic activity, synaptogenesis, GABAergic neurotransmission, neurotransmitter receptor expression and the hormonal control of neuroendocrine reproductive development. In this study, we cloned and characterized the cDNA of goose Nrg1 originating from hypothalamus tissues of Huoyan goose using RACE method, investigated the mRNA expression profiles during different stages of the egg-laying cycle by real-time PCR. Multiple alignments and phylogenetic analyses of the deduced amino acid sequence were conducted using bioinformatics tools. We also determined the profiles of blood serum progesterone, estradiol, FSH and LH content during different egg-laying stages using radioimmunoassay. The cDNA of Nrg1 is consisted of 2061bp open reading frame encoding 686 amino acids. The deduced amino acid sequence of goose Nrg1 contains one EGF domain from amino acid residues 224 to 265 and shows a closer genetic relationship to the avian species than to other mammal species. The expression level of Nrg1 mRNA increased from the pre-laying period to the peak-laying period, reached its peak in the peak-laying period, and then decreased in the ceased period. The concentrations of FSH and estradiol in blood serum have the similar changing trend. These results might suggest a potential correlation between Nrg1/ErbB signaling network with the reproductive neuroendocrine of Huoyan goose.
Subject(s)
Cloning, Molecular/methods , Geese/physiology , Gene Expression Profiling/methods , Neuregulin-1/genetics , Oviposition , Animals , Computational Biology/methods , Estradiol/blood , Follicle Stimulating Hormone/blood , Geese/genetics , Gene Expression Regulation , Hypothalamus/metabolism , Luteinizing Hormone/blood , Neuregulin-1/metabolism , Phylogeny , Progesterone/bloodABSTRACT
The multi-kinase inhibitor sorafenib is now used as standard therapy for advanced hepatocellular carcinoma (HCC). Predictive biomarkers of response to sorafenib are thus necessary. The purpose of this study was to assess the feasibility of using targeted DNA and RNA sequencing to elucidate candidate biomarkers of sorafenib response using fine-needle biopsy, formalin-fixed paraffin-embedded (FFPE) specimens in patients with HCC. Targeted DNA and RNA deep sequencing were feasible for the evaluation of fine-needle biopsy FFPE specimens obtained from 46 patients with HCC treated with sorafenib. Frequent mutations of suppressor genes, such as CTNNB1 (34.8%) and TP53 (26.1%), were detected in the HCC tumors. After excluding these suppressor genes, the average numbers of detected oncogene mutations differed significantly between the non-PD and PD groups (P = 0.0446). This result suggests that the oncogene mutational burden in the tumor might be associated with the clinical response to sorafenib. We have identified candidate gene expression (TGFa, PECAM1, and NRG1) in tumor for the prediction of sorafenib response and PFS by RNA sequencing. Our findings provide new insights into biomarkers for sorafenib therapy and allow us to discuss future therapeutic strategies.
Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Niacinamide/analogs & derivatives , Phenylurea Compounds/therapeutic use , Sequence Analysis, DNA , Sequence Analysis, RNA , Aged , Aged, 80 and over , Biomarkers/metabolism , Biomarkers, Tumor/metabolism , Biopsy, Fine-Needle , Carcinoma, Hepatocellular/drug therapy , Female , Formaldehyde/chemistry , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , High-Throughput Nucleotide Sequencing/methods , Humans , Liver Neoplasms/drug therapy , Male , Middle Aged , Mutation , Neuregulin-1/genetics , Niacinamide/therapeutic use , Paraffin Embedding , Platelet Endothelial Cell Adhesion Molecule-1/genetics , Sorafenib , Transforming Growth Factor alpha/genetics , Treatment Outcome , Tumor Suppressor Protein p53/genetics , beta Catenin/geneticsABSTRACT
Laminarin, found in marine brown algae, is used as a carbohydrate reserve for phytoplankton; however, it is also used in traditional Chinese medicine, and has been shown to have several biological activities, including anticancer activities. In this study, we examined the mechanisms through which laminarin from Laminaria digitata induces apoptosis in HT-29 colon cancer cells, as well as the involvement of the ErbB signaling pathway. Cell viability assay revealed that laminarin induced cell death in a dose-dependent manner. Cell cycle analysis revealed that laminarin increased the percentage of cells in the sub-G1 and G2-M phase. Western blot analysis demonstrated that laminarin inhibited the heregulin-stimulated phosphorylation of ErbB2. A decrease in cellular proliferation was also observed; this was found to be dependent on ErbB, which activates c-Jun N-terminal kinase. These findings demonstrate the important role of the epidermal growth factor receptor in colon cancer tumorigenesis, and suggest the potential of laminarin as a bio-functional food with anticancer effects on human colon cancer.
Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Colonic Neoplasms/metabolism , ErbB Receptors/metabolism , Polysaccharides/pharmacology , Signal Transduction/drug effects , Cell Cycle/drug effects , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Line, Tumor , Colonic Neoplasms/genetics , ErbB Receptors/genetics , Gene Expression Regulation, Neoplastic/drug effects , Glucans , HT29 Cells , Humans , Membrane Potential, Mitochondrial/drug effects , Neuregulin-1/genetics , Neuregulin-1/metabolism , Phosphorylation/drug effects , Proto-Oncogene Proteins c-akt/metabolismABSTRACT
The incidence of anxiety, mood, substance abuse disorders and schizophrenia increases during adolescence. Epidemiological evidence confirms that exposure to stress during sensitive periods of development can create vulnerabilities that put genetically predisposed individuals at increased risk for psychiatric disorders. Neuregulin 1 (NRG1) is a frequently identified schizophrenia susceptibility gene that has also been associated with the psychotic features of bipolar disorder. Previously, we established that Type II NRG1 is expressed in the hypothalamic-pituitary-adrenal (HPA) axis neurocircuitry. We also found, using a line of Nrg1 hypomorphic rats (Nrg1(Tn)), that genetic disruption of Type II NRG1 results in altered HPA axis function and environmental reactivity. The present studies used the Nrg1(Tn) rats to test whether Type II NRG1 gene disruption and chronic stress exposure during adolescence interact to alter adult anxiety- and fear-related behaviors. Male and female Nrg1(Tn) and wild-type rats were exposed to chronic variable stress (CVS) during mid-adolescence and then tested for anxiety-like behavior, cued fear conditioning and basal corticosterone secretion in adulthood. The disruption of Type II NRG1 alone significantly impacts rat anxiety-related behavior by reversing normal sex-related differences and impairs the ability to acquire cued fear conditioning. Sex-specific interactions between genotype and adolescent stress also were identified such that CVS-treated wild-type females exhibited a slight reduction in anxiety-like behavior and basal corticosterone, while CVS-treated Nrg1(Tn) females exhibited a significant increase in cued fear extinction. These studies confirm the importance of Type II NRG1 in anxiety and fear behaviors and point to adolescence as a time when stressful experiences can shape adult behavior and HPA axis function.
Subject(s)
Anxiety/genetics , Anxiety/metabolism , Fear/physiology , Neuregulin-1/deficiency , Neuregulin-1/genetics , Adrenal Glands/physiology , Age Factors , Animals , Anxiety/psychology , Chronic Disease , Fear/psychology , Female , Hypothalamus/physiology , Male , Pituitary Gland/physiology , Rats , Rats, Inbred F344 , Rats, TransgenicABSTRACT
The human neuregulin-1 (NRG-1) gene is highly expressed in the brain, is implicated in numerous functions associated with neuronal development, and is a leading candidate gene for schizophrenia. The T allele of SNP8NRG243177, part of a risk haplotype for schizophrenia, has been previously associated with decreases in white matter in the right anterior internal capsule and the left anterior thalamic radiation. To our knowledge no studies have described the effects of SNP8NRG243177 on grey matter volume at a voxelwise level. We assessed associations between this SNP and brain structure in 79 general population volunteers from the Northern Finland 1966 Birth Cohort (NFBC 1966). We show, for the first time, that genetic variation in SNP8NRG243177 is associated with variation in frontal brain structure in both grey and white matter. T allele carriers showed decreased grey matter volume in several frontal gyri, including inferior, middle and superior frontal gyri and the anterior cingulate gyrus, as well as decreased white matter volume in the regions of the genu and body of the corpus callosum, anterior and superior corona radiata, anterior limb of the internal capsule and external capsule regions traversed by major white matter tracts of the anterior thalamic radiation, and the inferior fronto-occipital fasciculus. These results suggest that this genetic variant may mediate risk for schizophrenia, in part, through its effect on brain structure in these regions.
Subject(s)
Brain/anatomy & histology , Neuregulin-1/genetics , Adult , Alleles , Brain Mapping , Cognition/physiology , Cohort Studies , DNA/genetics , Female , Finland , Genetic Predisposition to Disease , Genotype , Humans , Image Processing, Computer-Assisted , Intelligence Tests , Linear Models , Male , Polymerase Chain Reaction , Polymorphism, Single Nucleotide , Schizophrenia/pathology , Sex Characteristics , Thalamus/anatomy & histologyABSTRACT
Evidence suggests that the heterozygous transmembrane domain mutant mouse model for the schizophrenia candidate gene neuregulin 1 (Nrg1 HET) exhibits a deficit in prepulse inhibition (PPI). However, not all mouse models for Nrg1 exhibit PPI deficits. Thus, our study intended to clarify the severity of the initially described PPI deficit in Nrg1 HET mice. For this, Nrg1 mutant mice and wild type-like littermates of one breeding colony were tested for PPI in four different phenotyping facilities in Australia employing a variety of different PPI protocols with fixed and variable interstimulus intervals (ISIs). Testing mutant and wild type-like mice in three Australian phenotyping facilities using PPI protocols with variable ISIs revealed no effect of mutant transmembrane domain Nrg1 on sensorimotor gating. Changes to the startle response and startle response habituation were site/protocol-specific. The employment of two different PPI protocols at the same phenotyping facility revealed a protocol-dependent and site-specific facilitation of PPI in Nrg1 mutant mice compared to wild type-like mice. In conclusion, the often-noted PPI phenotype of the transmembrane domain Nrg1 mutant mouse model is highly PPI protocol-specific and appears sensitive to the particular conditions of the test laboratory. Our study describes wild type-like PPI under most test conditions and across three different laboratories. The research suggests that analysing one of the alleged hallmarks of animal models for schizophrenia must be done carefully: to obtain reliable PPI data it seems necessary to use more than one particular PPI protocol.
Subject(s)
Mutation/physiology , Neuregulin-1/genetics , Neuregulin-1/physiology , Sensory Gating/genetics , Sensory Gating/physiology , Acoustic Stimulation , Animals , Disease Models, Animal , Habituation, Psychophysiologic/genetics , Habituation, Psychophysiologic/physiology , Male , Membrane Potentials/physiology , Mice , Reflex, Startle/physiology , SchizophreniaABSTRACT
Age-related synaptic change is associated with the functional decline of the nervous system. It is unknown whether this synaptic change is the cause or the consequence of neuronal cell loss. We have addressed this question by examining mice genetically engineered to over- or underexpress neuregulin-1 (NRG1), a direct modulator of synaptic transmission. Transgenic mice overexpressing NRG1 in spiral ganglion neurons (SGNs) showed improvements in hearing thresholds, whereas NRG1 -/+ mice show a complementary worsening of thresholds. However, no significant change in age-related loss of SGNs in either NRG1 -/+ mice or mice overexpressing NRG1 was observed, while a negative association between NRG1 expression level and survival of inner hair cells during aging was observed. Subsequent studies provided evidence that modulating NRG1 levels changes synaptic transmission between SGNs and hair cells. One of the most dramatic examples of this was the reversal of lower hearing thresholds by "turning-off" NRG1 overexpression. These data demonstrate for the first time that synaptic modulation is unable to prevent age-related neuronal loss in the cochlea.
Subject(s)
Aging/metabolism , Cochlea/metabolism , Synapses/physiology , Acoustic Stimulation/methods , Aging/pathology , Animals , Cell Count/methods , Cell Survival/physiology , Cochlea/innervation , Cochlea/pathology , Hearing Loss/metabolism , Hearing Loss/pathology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neuregulin-1/genetics , Neuregulin-1/physiology , Spiral Ganglion/pathology , Synapses/pathology , Synaptic Transmission/physiologyABSTRACT
Fast axonal conduction depends on myelin, which is formed by Schwann cells in the PNS. We found that the transcription factor Yin Yang 1 (YY1) is crucial for peripheral myelination. Conditional ablation of Yy1 in the Schwann cell lineage resulted in severe hypomyelination, which occurred independently of altered Schwann cell proliferation or apoptosis. In Yy1 mutant mice, Schwann cells established a 1:1 relationship with axons but were unable to myelinate them. The Schwann cells expressed low levels of myelin proteins and of Egr2 (also called Krox20), which is an important regulator of peripheral myelination. In vitro, Schwann cells that lacked Yy1 did not upregulate Egr2 in response to neuregulin1 and did not express myelin protein zero. This phenotype was rescued by overexpression of Egr2. In addition, neuregulin-induced phosphorylation of YY1 was required for transcriptional activation of Egr2. Thus, YY1 emerges as an important activator of peripheral myelination that links neuregulin signaling with Egr2 expression.
Subject(s)
Early Growth Response Protein 2/physiology , Nerve Fibers, Myelinated/physiology , Neuregulin-1/physiology , Peripheral Nerves/physiology , Transcription, Genetic/physiology , YY1 Transcription Factor/physiology , Animals , Cells, Cultured , Early Growth Response Protein 2/biosynthesis , Early Growth Response Protein 2/genetics , Gene Knockout Techniques , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nerve Fibers, Myelinated/metabolism , Neuregulin-1/biosynthesis , Neuregulin-1/genetics , Peripheral Nerves/metabolism , Rats , Schwann Cells/physiology , YY1 Transcription Factor/biosynthesis , YY1 Transcription Factor/geneticsABSTRACT
Numerous genetic studies associated the Neuregulin 1 (NRG1) Icelandic haplotype (HAP(ice)), and its single nucleotide polymorphism SNP8NRG243177 [T/T], with schizophrenia. Because SNP8NRG243177 [T/T] has characteristics of a functional polymorphism that maps close to NRG1 type IV coding sequences, our initial goal was to map precisely the human type IV transcription initiation site. We determined that the initiation site is 23 bp upstream of the previously reported type IV exon, and that no other transcripts map to the SNP8NRG243177 region. Because NRG1 type IV transcripts are specific to human, we isolated full-length NRG1 type IV cDNAs from human hippocampi and expressed them in non-neural cells and dissociated rat hippocampal neurons to study protein expression, processing and function. Using an antiserum we generated against the NRG1 type IV-specific N-terminus, we found that the protein is targeted to the cell surface where PKC activation promotes its cleavage and release of the extracellular domain. Conditioned medium derived from type IV expressing cells stimulates ErbB receptor phosphorylation, as well as downstream Akt and Erk signaling, demonstrating that NRG1 type IV possesses biological activity similar to other releasable NRG1 isoforms. To study the subcellular targeting of distinct isoforms, neurons were transfected with the Ig-domain-containing NRG1 types I and IV, or the cysteine-rich domain type III isoform. Three dimensional confocal images from transfected neurons indicate that, whereas all isoforms are expressed on somato-dendritic membranes, only the type III-cysteine-rich domain isoform is detectable in distal axons. These results suggest that NRG1 type IV expression levels associated with SNP8NRG243177 [T/T] can selectively modify signaling of NRG1 released from somato-dendritic compartments, in contrast to the type III NRG1 that is also associated with axons.
Subject(s)
Neuregulin-1/chemistry , Neuregulin-1/genetics , Animals , Brain/physiology , Cell Line , Cells, Cultured , DNA, Complementary/biosynthesis , DNA, Complementary/genetics , Gene Targeting , Glycosylation , Humans , Immunoblotting , Immunohistochemistry , Isomerism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Neuregulin-1/isolation & purification , Neurons/metabolism , Phorbol Esters/pharmacology , Protein Kinase C/physiology , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Stimulation, Chemical , Subcellular Fractions/metabolism , Transcription, Genetic/geneticsABSTRACT
BACKGROUND: Prepulse inhibition (PPI) of the acoustic startle response (ASR) is an operational measure of sensorimotor gating and a promising endophenotype of schizophrenia. We have recently shown that the linked serotonin-2A receptor (5-HT(2A)R) A-1438 G and T102C polymorphisms modulate PPI in schizophrenia patients. Moreover, it was shown that genetic variation in the catechol-O-methyltransferase (COMT) and the neuregulin-1 (NRG-1) proteins influences PPI in schizophrenia patients and healthy volunteers. Therefore, we aimed to replicate these results and investigated the impact of the related polymorphisms on PPI in healthy human volunteers. METHODS: We analyzed the 5-HT(2A)R A-1438 G/T102C (rs6311/rs6313), the COMT Val158Met (rs4680), and the NRG-1 Arg38Gln (rs3924999) polymorphisms, assessing startle reactivity, habituation, and PPI of ASR in 107 healthy Caucasian volunteers. RESULTS: Subjects homozygous for the 5-HT(2A)R T102C-T/A-1438 G-A allele showed increased PPI levels. In particular, male subjects with the COMT Met158Met-genotype also showed elevated PPI. The NRG-1 Arg38Gln genotype did not have a significant impact on PPI. Startle reactivity was not affected by any of the investigated polymorphisms. CONCLUSIONS: We confirmed in an independent sample of healthy volunteers that PPI is influenced by genetic variation in the 5-HT(2A)R gene. The influence of the COMT Val158Met genotype on PPI appears to be sex-specific. These results underscore the significance of the serotonin and dopamine systems in the modulation of sensorimotor gating.
Subject(s)
Arginine/genetics , Catechol O-Methyltransferase/genetics , Glutamine/genetics , Neuregulin-1/genetics , Receptor, Serotonin, 5-HT2A/genetics , Sensory Gating/genetics , Acoustic Stimulation/methods , Adolescent , Adult , Analysis of Variance , Female , Genotype , Humans , Male , Neural Inhibition/genetics , Reflex, Startle/genetics , Sex Factors , Statistics as Topic , Young AdultABSTRACT
Neuregulin 1 (Nrg1) has been widely recognized as a candidate gene for schizophrenia. This study therefore investigated mice heterozygous for a mutation in the transmembrane domain of this trophic factor (Nrg1+/- mice) in a number of behavioural test systems with relevance to schizophrenia, including psychotropic drug-induced locomotor hyperactivity and prepulse inhibition (PPI) of startle. Baseline locomotor activity in the open field or in photocell cages was slightly, but significantly enhanced in Nrg1+/- mice compared to wild-type littermate controls at age 12-16 wk, but not at age 6 months. The ability of amphetamine, phencyclidine (PCP) or MK-801 to induce locomotor hyperactivity was not significantly different between the genotypes. There was no difference in baseline PPI, startle or startle habituation and there was no difference in the effect of apomorphine, amphetamine or MK-801 on any of these parameters. Only treatment with the 5-HT1A receptor agonist 8-hydroxy-dipropylaminotetralin (8-OH-DPAT) showed a differential effect between genotypes, with a disruption of PPI occurring in Nrg1+/- mice compared to no effect in wild-type controls. This treatment also induced a significant reduction of startle which could have influenced the result. The density of dopamine D2 receptors in the forebrain and of 5-HT1A receptors in the hippocampus and raphe nuclei was not different between Nrg1+/- mice and controls. These studies add to the knowledge about behavioural effects in this mouse model of impaired Nrg1 function and suggest that a number of the behavioural tests with relevance to schizophrenia are normal in these mice.
Subject(s)
Hyperkinesis/chemically induced , Hyperkinesis/genetics , Motor Activity/physiology , Neuregulin-1/physiology , Psychotropic Drugs/pharmacology , Reflex, Startle/physiology , Acoustic Stimulation/methods , Animals , Dose-Response Relationship, Drug , Male , Mice , Mice, Mutant Strains , Motor Activity/drug effects , Neuregulin-1/genetics , Psychotropic Drugs/toxicity , Reflex, Startle/drug effectsABSTRACT
Vitamin A, an essential nutrient, is required in its acidic form (retinoic acid) for normal embryogenesis and neuronal development, typically within well-defined concentration ranges. In zebra finches, a songbird species, localized retinoic acid synthesis in the brain is important for the development of song, a learned behavior sharing significant commonalities with speech acquisition in humans. We tested how dietary retinoic acid affects the development of song behavior and the brain's system for song control. Supplemental doses of retinoic acid given to juveniles during the critical period for song learning resulted in more variable or plastic-like songs when the birds reached adulthood, compared to the normal songs of vehicle-fed controls. We also observed that several genes (brinp1, nrgn, rxr-alpha, and sdr2/scdr9) had altered levels of expression in specific nuclei of the song system when comparing the experimental and control diet groups. Interestingly, we found significant correlations between gene expression levels in nuclei of the anterior forebrain pathway (lMAN and area X) and the degree of variability in the recorded songs. We observed, however, no major morphological effects such as changes in the volumes of song nuclei. Overall, our results lend further support to a fundamental role of retinoic acid in song maturation and point to possible molecular pathways associated with this action. The data also demonstrate that dietary content of Vitamin A can affect the maturation of a naturally learned complex behavior.
Subject(s)
Brain/physiology , Finches/physiology , Food, Formulated , Gene Expression Regulation, Developmental/physiology , Tretinoin/metabolism , Vocalization, Animal/physiology , Aging/genetics , Aging/metabolism , Animals , Brain/anatomy & histology , Brain/drug effects , Critical Period, Psychological , Finches/metabolism , Gene Expression Regulation, Developmental/drug effects , High Vocal Center/drug effects , High Vocal Center/growth & development , High Vocal Center/metabolism , Learning/drug effects , Learning/physiology , Male , Nerve Tissue Proteins/genetics , Neural Pathways/drug effects , Neural Pathways/growth & development , Neural Pathways/metabolism , Neuregulin-1/genetics , Prosencephalon/drug effects , Prosencephalon/growth & development , Prosencephalon/metabolism , Receptors, Cell Surface/genetics , Retinoid X Receptor alpha/genetics , Sound Spectrography , Tretinoin/pharmacology , Vitamin A/metabolism , Vocalization, Animal/drug effectsABSTRACT
Neuronal migration and axon guidance constitute fundamental processes in brain development that are generally studied independently. Although both share common mechanisms of cell biology and biochemistry, little is known about their coordinated integration in the formation of neural circuits. Here we show that the development of the thalamocortical projection, one of the most prominent tracts in the mammalian brain, depends on the early tangential migration of a population of neurons derived from the ventral telencephalon. This tangential migration contributes to the establishment of a permissive corridor that is essential for thalamocortical axon pathfinding. Our results also demonstrate that in this process two different products of the Neuregulin-1 gene, CRD-NRG1 and Ig-NRG1, mediate the guidance of thalamocortical axons. These results show that neuronal tangential migration constitutes a novel mechanism to control the timely arrangement of guidance cues required for axonal tract formation in the mammalian brain.
Subject(s)
Axons/physiology , Cell Movement , Cerebral Cortex/cytology , Neuregulin-1/metabolism , Thalamus/cytology , Animals , Biological Transport , COS Cells , Cerebral Cortex/metabolism , Chlorocebus aethiops , ErbB Receptors/deficiency , Ganglion Cysts/metabolism , Mice , Mice, Transgenic , Neuregulin-1/deficiency , Neuregulin-1/genetics , Protein Isoforms , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptor, ErbB-4 , Telencephalon/cytology , Thalamus/metabolismABSTRACT
ErbB receptor tyrosine kinases play an important role in developmental processes and tumor formation. Their activity is regulated by a family of structurally related ligands that bind to distinct ErbB receptor subsets, with transforming growth factor (TGF)-alpha preferentially interacting with epidermal growth-factor receptor (EGFR) and heregulin (HRG)-beta1 recognizing ErbB3 and ErbB4. To investigate the contribution of N-terminal ligand sequences to binding specificity, we have constructed 2 chimeric growth factors termed H181T8 and H194T20, which contain N-terminal HRG-beta1 sequences linked to complementary fragments of TGF-alpha. For bacterial expression and analysis of cell binding, the chimeric ligands were genetically fused to truncated Pseudomonas exotoxin A (ETA). H181T8-ETA and H194T20-ETA toxins both were cytotoxic for human tumor cell lines overexpressing EGFR but did not significantly affect the growth of cells that express ErbB receptors other than EGFR. Binding of H181T8, which contains HRG-beta1 residues 177-181, induced rapid autophosphorylation of EGFR, but in contrast to a previously described chimeric ligand based on EGF was unable to activate other ErbB receptors. H194T20, which contains HRG-beta1 residues 177-194, despite specific binding to EGFR was unable to induce autophosphorylation of any of the ErbB family members. However, H194T20 enhanced and modified the activity of parental TGF-alpha and HRG-beta1 when these ligands were simultaneously present. Our results show that modification of the N-terminal TGF-alpha sequence can have a significant effect on the signaling properties of the ligand and suggest that different EGF-like ligands can synergize in the activation of ErbB receptors.
Subject(s)
ADP Ribose Transferases , Bacterial Toxins , Neuregulin-1/chemistry , Neuregulin-1/genetics , Transforming Growth Factor alpha/chemistry , Transforming Growth Factor alpha/genetics , Virulence Factors , Amino Acid Sequence , Binding, Competitive , Cell Survival , Culture Media, Serum-Free/metabolism , Dimerization , Dose-Response Relationship, Drug , Enzyme Activation , ErbB Receptors/metabolism , Exotoxins/pharmacology , Ligands , Molecular Sequence Data , Mutation , Phosphorylation , Phosphotyrosine/metabolism , Protein Binding , Protein Structure, Tertiary , Recombinant Fusion Proteins/metabolism , Recombinant Proteins/metabolism , Signal Transduction , Time Factors , Transforming Growth Factor alpha/metabolism , Tumor Cells, Cultured , Tyrosine/metabolism , Pseudomonas aeruginosa Exotoxin AABSTRACT
The development of functional Ca(2+)-activated K(+) channels (K(Ca)) in chick ciliary ganglion (CG) neurons requires interactions with afferent preganglionic nerve terminals. Here we show that the essential preganglionic differentiation factor is an isoform of beta-neuregulin-1. beta-Neuregulin-1 transcripts are expressed in the midbrain preganglionic Edinger-Westphal nucleus at developmental stages that coincide with or precede the normal onset of macroscopic K(Ca) in CG neurons. Injection of beta-neuregulin-1 peptide into the brains of developing embryos evoked a robust stimulation of functional K(Ca) channels at stages before the normal appearance of these channels in CG neurons developing in vivo. Conversely, injection of a neutralizing antiserum specific for beta-neuregulin-1 inhibited the development of K(Ca) channels in CG neurons. Low concentrations of beta-neuregulin-1 evoked a robust increase in whole-cell K(Ca) in CG neurons cocultured with iris target tissues. By contrast, culturing CG neurons with iris cells or low concentrations of beta-neuregulin-1 by themselves was insufficient to stimulate K(Ca). These data suggest that the preganglionic factor required for the development of K(Ca) in ciliary ganglion neurons is an isoform of beta-neuregulin-1, and that this factor acts in concert with target-derived trophic molecules to regulate the differentiation of excitability.
Subject(s)
Calcium/metabolism , Neuregulin-1/physiology , Neurons/metabolism , Parasympathetic Nervous System/metabolism , Potassium Channels/physiology , Animals , Base Sequence , Chick Embryo , Coculture Techniques , DNA Primers , DNA, Complementary , Neuregulin-1/genetics , Parasympathetic Nervous System/cytology , Parasympathetic Nervous System/embryology , Potassium Channels/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolismABSTRACT
AIM: To study the effects of bilobalide on the expression of glial cell line-derived neurotrophic factor (GDNF) and vascular endothelial growth factor (VEGF) in rat astrocytes in vitro. METHODS: Semiquantification polymerase chain reaction (SQ-PCR) was used to investigate GDNF and VEGF mRNA expression in the astrocytes after bilobalide (5, 15, 50, 100 mumol.L-1) treatment. Immunohistochemistry method was used to detect GDNF and VEGF protein expression in cells treated with bilobalide 50 mumol.L-1 for 24 h. RESULTS: GDNF and VEGF mRNA increased markedly after astrocytes were treated with bilobalide 50 mumol.L-1 for 12 h. GDNF and VEGF protein were detected in the cytoplasm of astrocytes after the cells were treated with bilobalide 50 mumol.L-1 for 24 h. CONCLUSION: Bilobalide induced GDNF and VEGF expression in the cultured astrocytes.